期刊文献+

UbcH10基因沉默对耐药乳腺癌细胞MCF-7/TXT药物敏感性影响

Effects of UbcH10 gene silencing on drug sensitivity of drug resistant breast cancer cell MCF-7/TXT
下载PDF
导出
摘要 目的观察UbcH10基因沉默对MCF-7/TXT细胞耐药的影响。方法设计针对UbcH10的siRNA序列,构建shRNA表达载体并进行重组慢病毒包装,重组病毒感染MCF-7/TXT细胞,转染后72 h通过荧光标记物确认细胞感染效率,收集转染后细胞,Real-Time PCR和Western blotting分别检测转染后细胞内UbcH10mRNA及蛋白含量变化;CCK-8检测基因沉默对MCF-7/TXT化疗药物敏感性的影响。结果在MCF-7/TXT细胞中成功进行了UbcH10基因沉默实验,病毒感染后72 h细胞的感染效率达到约90%,细胞内UbcH10mRNA和蛋白相对含量明显降低,与对照组比较差异具有统计学意义(P<0.05);UbcH10基因沉默可以明显增强MCF-7/TXT对多西他赛的药物敏感性,多西他赛对基因干预组和对照组细胞的不同时间点IC50值明显降低,差异具有统计学意义(P<0.05)。结论 UbcH10沉默可显著增强乳腺癌耐药细胞MCF-7/TXT对多西他赛的化疗敏感性。 Objective To investigate the effects of U bcH10 gene silencing on the drug resistance of human breast cancer cell MCF-7 /TXT. Methods The shRNA expression vectors were constructed using the siRNA sequences which were designed based on the coding sequence of U bcH10. MCF-7 /TXT cells were then infected by lentivirus. After being infected for 72 h, the infection efficiency was observed through the fluorescent marker and infected cells were collected.The variations of U bcH10 mRNA and protein levels of infected cells were detected by the Real-Time PC R and Western blotting, respectively.The effects of gene silencing on the sensitivity of chemotherapeutic drugs for MCF-7 /TXT cells were detected by the CCK-8. Results The gene silencing test of MCF-7/TXT cells was successfully. After being infected for 72 h, the infection efficiency was about 90% and U bcH10 mRNA and protein levels of infected cells significantly decreased.Compared to the control group, the differences were statistically significant( P〈 0. 05). Silencing the U bcH10 gene significantly enhanced the drug sensitivity of taxotere towards MCF-7 /TXT cells. IC50 values of taxotere of the gene silencing group at different time points were significantly lower than those of the control group.The differences were statistically significant( P 〈0. 05). Conclusion Silencing the U bcH10 gene can significantly enhance the chemotherapy sensitivity of drug resistant breast cancer cell MCF-7 /TXT towards taxotere.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第10期1448-1453,共6页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市医学重点专科建设项目(ZK2012A13)~~
关键词 MCF-7/TXT siRNA 慢病毒 UBCH10 耐药性 MCF-7/TXT siRNA Lentivirus UbcH10 drug resistance
  • 相关文献

参考文献18

  • 1邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
  • 2吴炅,杨犇龙.2012年乳腺癌研究进展回顾[J].中华乳腺病杂志(电子版),2013,7(1):4-6. 被引量:17
  • 3胡小辉,李建文.RNA干扰技术在乳腺癌治疗中的研究进展[J].中华乳腺病杂志(电子版),2013,7(1):47-51. 被引量:4
  • 4李强,王兴武,宋宝.microRNA-21对乳腺癌MCF-7/ADR细胞株多柔比星耐药性影响的研究[J].中华肿瘤防治杂志,2012,19(3):188-191. 被引量:12
  • 5Donato G, Iofrida G, Lavano A, et al. Analysis of UbeH10 expres- sion represents a useful tool for the diagnosis and therapy of astroey- tie tumors [ J ]. Clin Neuropathol, 2008, 27 (4) : 219 - 223.
  • 6Berlingieri MT, Pallante P, Guida M, et al. UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas[J]. Oncogene, 2007, 26(14) : 2136 - 2140.
  • 7Ieta K, Ojima E, Tanaka F, et al. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin- conjugating enzyme E2C gene expression[ J]. Int J Cancer, 2007, 121(1): 33-38.
  • 8Fujita T, Ikeda H, Kawasaki K, et al. Clinicopathological relevance of UbcH10 in breast cancer[J]. Cancer Sci, 2008, 100 (2): 238 - 248.
  • 9王银平,殷志强,陈雪华,季福,刘炳亚,孙婧璟.UbcH10在乳腺癌中的表达及意义[J].外科理论与实践,2008,13(2):149-152. 被引量:5
  • 10Aristarkhov A, Eytan E, Moghe A ubiquitin carrier protein required cyclones[J]. Proc Natl Acad Sci , et al. E2-C, a eyclin selective for the destruction of mitotic U S A, 1996, 93(9): 4294- 4299.

二级参考文献29

  • 1Aristarkhov A, Eytan E, Moghe A, et al. E2-C, a cyclinselective ubiquitin carrier protein required for the destruction of mitotic cyclins[J]. Proc Natl Acad Sci U S A, 1996,93(9):4294-4299.
  • 2Lin Y, Hwang WC, Basavappa R. Structural and functional analysis of the human mitotic-specific ubiquitinconjugating enzyme, UbcH10[J]. J Biol Chem,2002,277 (24):21913-21921.
  • 3Townsley FM, Aristarkhov A, Beck S, et al. Dominantnegative cyclin-selective ubiquitin carrier protein E2-C/ UbcH10 blocks cells in metaphase[J]. Proc Natl Acad Sci U S A,1997,94(6):2362-2367.
  • 4Okamoto Y, Ozaki T, Miyazaki K, et al. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme[J]. Cancer Res,2003,63(14):4167-4173.
  • 5Pallante P, Berlingieri MT, Troncone G, et al. UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas[J]. Br J Cancer,2005,93(4):464-471.
  • 6Berlingieri MT, Pallante P, Sboner A, et al. UbcH10 is overexpressed in malignant breast carcinomas [J]. Eur J Cancer,2007,43(18):2729-2735.
  • 7Okamoto Y, Ozaki T, Miyazaki K, et al. UbcH10 is the cancer- related E2 ubiquitin-conjugating enzyme [ J ]. Cancer Res, 2003, 63( 14): 4167-4173.
  • 8Lin J, Raoof DA, Wang Z, et al. Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenot:arci- noma[J]. Neoplasia, 2006, 8(12): 1062-1071.
  • 9Troncone G, Guerriero E, Pallante P, et al. UbcH10 expression in human lymphoma[J]Histopatbology, 2009, 54 (6) : 73 l - 740.
  • 10Berlingieri MT, Pallante P, Sboner A, et al. UbcHl0 is overcx- pressed in malignant breast carcinomas[ J]. Eur J Cancer, 2007, 43(18) : 2729 -2735.

共引文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部